Octagon Capital Advisors
New York City, New Yorkoctagoncapital.com
Overview
Octagon Capital Advisors is a hedge fund manager that invests in public and private healthcare companies globally.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Numab | Jan 2025 | Series C Extension | - |
| Aktis Oncology | Aug 2022 | Series A Extension | - |
| Sonoma Biotherapeutics | Aug 2021 | Series B | - |
| NiKang Therapeutics | May 2021 | Series C | Lead |
| Numab | May 2021 | Series C | - |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.